stella
beta
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer — Stella
Home
/
HNSCC
/
View on ClinicalTrials.gov
Recruiting
Back to HNSCC trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
United States
Vanderbilt University Medical Center, Nashville, Tennessee